Other languages Tibet AIM Pharm. Inc.

Equities

002826

CNE100002C39

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 29/04/2024 BST			5-day change	1st Jan Change
8.91 ^CNY	+0.34%		+16.93%	-24.94%

04-26	Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023	CI
04-25	Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023	04-26
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25
Tibet AIM Pharm. Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	29/10/23
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Tibet AIM Pharm. Inc. authorizes a Buyback Plan.	25/10/23
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23
Tibet AIM Pharm. Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 07 July 2023	30/06/23
Tibet AIM Pharm. Inc. Approves Cash Dividend for 2022	19/05/23
Tibet Aim Pharm. Inc. Proposes Final Cash Dividend for the Year 2022	27/04/23
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/03/23
Tibet Aim Pharm Chairman Resigns; Successor Named	13/02/23
Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million	13/02/23
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22
Tibet Aim Pharm. Inc. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares) for the Year 2021, Payable on 8 July 2022	01/07/22
Tibet AIM Pharm. Inc. Approves 2021 Profit Distribution Plan	19/05/22
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22
Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for the Year 2021	22/04/22
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	08/04/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Tibet AIM Pharm. Inc.

Equities

002826

CNE100002C39

Other languages

Filters